HSBC Holdings
DNA icon

HSBC Holdings’s Ginkgo Bioworks DNA Stock Holding History

HSBC Holdings’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,366
Closed -$31.4K – 3020
2024
Q2 		$31.4K Buy
2,366
+850
+56% +$25.4K ﹤0.01% 2853
2024
Q1 		$70.3K Sell
1,516
-127
-8% -$6.57K ﹤0.01% 2899
2023
Q4 		$110K Sell
1,643
-17
-1% -$1.04K ﹤0.01% 2588
2023
Q3 		$121K Buy
1,660
+347
+26% +$27.7K ﹤0.01% 2527
2023
Q2 		$99.8K Sell
1,313
-2,645
-67% -$157K ﹤0.01% 2428
2023
Q1 		$214K Buy
3,958
+1,356
+52% +$85.9K ﹤0.01% 2362
2022
Q4 		$171K Buy
2,602
+15
+0.6% +$1.38K ﹤0.01% 2809
2022
Q3 		$326K Buy
2,587
+1,224
+90% +$146K ﹤0.01% 2371
2022
Q2 		$132K Buy
1,363
+872
+178% +$106K ﹤0.01% 2985
2022
Q1 		$80K Hold
491
– – ﹤0.01% 3155
2021
Q4 		$168K Buy
+491
New +$233K ﹤0.01% 3070

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return